[go: up one dir, main page]

AU4317396A - Novel thiazolidin-4-one derivatives - Google Patents

Novel thiazolidin-4-one derivatives

Info

Publication number
AU4317396A
AU4317396A AU43173/96A AU4317396A AU4317396A AU 4317396 A AU4317396 A AU 4317396A AU 43173/96 A AU43173/96 A AU 43173/96A AU 4317396 A AU4317396 A AU 4317396A AU 4317396 A AU4317396 A AU 4317396A
Authority
AU
Australia
Prior art keywords
derivatives
thiazolidin
novel
novel thiazolidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43173/96A
Inventor
Jongsik Gam
Ki-Seung Lee
Don Soo Park
Jeong Ho Park
Jung Soo Park
Pyeong-Uk Park
Sungsoo Pyo
Keun Ho Ryu
Jin Heung Sung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SK Discovery Co Ltd
Original Assignee
Sunkyung Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sunkyung Industries Ltd filed Critical Sunkyung Industries Ltd
Publication of AU4317396A publication Critical patent/AU4317396A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/10Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU43173/96A 1994-12-29 1995-12-29 Novel thiazolidin-4-one derivatives Abandoned AU4317396A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR9438787 1994-12-29
KR19940038787 1994-12-29
PCT/KR1995/000183 WO1996020936A1 (en) 1994-12-29 1995-12-29 Novel thiazolidin-4-one derivatives

Publications (1)

Publication Number Publication Date
AU4317396A true AU4317396A (en) 1996-07-24

Family

ID=19405013

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43173/96A Abandoned AU4317396A (en) 1994-12-29 1995-12-29 Novel thiazolidin-4-one derivatives

Country Status (8)

Country Link
EP (1) EP0748317A1 (en)
JP (1) JPH09503792A (en)
KR (1) KR960022486A (en)
CN (1) CN1142227A (en)
AU (1) AU4317396A (en)
CA (1) CA2184174A1 (en)
HU (1) HU9602263D0 (en)
WO (1) WO1996020936A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970032857A (en) * 1995-12-29 1997-07-22 김준웅 Pharmaceutical composition
US6174908B1 (en) 1999-05-10 2001-01-16 Icagen, Inc. Potassium channel inhibitors
EP1082315A1 (en) 1998-06-05 2001-03-14 Icagen, Inc. Potassium channel inhibitors
AU4249700A (en) * 1999-04-19 2000-11-02 Sumitomo Pharmaceuticals Company, Limited Hydroxamic acid derivative
US6506751B1 (en) 1999-11-12 2003-01-14 Millennium Pharmaceuticals, Inc. Thiazolidinone compounds useful as chemokine inhibitors
US6713477B1 (en) 2000-04-19 2004-03-30 Sumitomo Pharmaceuticals Company, Limited Hydroxamic acid derivatives
WO2002013818A1 (en) * 2000-08-15 2002-02-21 South Alabama Medical Science Foundation Treating sickle cell disease
EP1343502A2 (en) 2000-11-17 2003-09-17 Idenix (Cayman) Limited Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines
US20030073712A1 (en) 2001-07-23 2003-04-17 Bing Wang Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
MXPA04005864A (en) 2001-12-19 2004-10-29 Atherogenics Inc Chalcone derivatives and their use to treat diseases.
US7173129B2 (en) 2003-06-06 2007-02-06 Athero Genics, Inc. Sulfonamide-substituted chalcone derivatives and their use to treat diseases
CA2545582C (en) 2003-11-21 2013-04-16 Actelion Pharmaceuticals Ltd 5-(benz-(z)-ylidene)-thiazolidin-4-one derivatives as immunosuppressant agents
USRE43833E1 (en) 2003-11-21 2012-11-27 Actelion Pharmaceuticals Ltd. Thiazolidin-4-one derivatives
CA2560664A1 (en) 2004-03-02 2005-09-09 Dainippon Sumitomo Pharma Co., Ltd. Benzothiazin-3-one compound and intermediate therefor
CA2669069C (en) 2006-11-23 2015-02-17 Actelion Pharmaceuticals Ltd Process for the preparation of 2-imino-thiazolidin-4-one derivatives
US8912340B2 (en) 2006-11-23 2014-12-16 Actelion Pharmaceuticals Ltd. Process for the preparation of 2-imino-thiazolidin-4-one derivatives
HUE050733T2 (en) 2012-08-17 2021-01-28 Actelion Pharmaceuticals Ltd Process (2Z, 5Z) -5- (3-chloro-4 - ((R) -2,3-dihydroxypropoxy) benzylidene) -2- (propylimino) -3- (O-tolyl) thiazolidin-4-one and an intermediate used in this process
KR102337399B1 (en) * 2019-10-02 2021-12-09 주식회사 클로소사이언스 Compounds that induces anti-aging gene klotho and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992455A (en) * 1987-05-22 1991-02-12 Sumitomo Pharmaceuticals Company, Limited Thiazolidin-4-one derivatives useful for treating diseases caused by platelet activating factor
ATE81123T1 (en) * 1987-11-20 1992-10-15 Hoechst Roussel Pharma 3-(4(1-SUBSTITUTED-4-PIPERAZINYL)BUTYL>-4THIAZOLIDINONES, PROCESS FOR THEIR PRODUCTION AND USE AS A MEDICINAL PRODUCT.
JPH01190679A (en) * 1988-01-22 1989-07-31 Sumitomo Pharmaceut Co Ltd New optically active thiazolidin-4-one derivatives and acid addition salts thereof

Also Published As

Publication number Publication date
WO1996020936A1 (en) 1996-07-11
KR960022486A (en) 1996-07-18
CA2184174A1 (en) 1996-07-11
JPH09503792A (en) 1997-04-15
CN1142227A (en) 1997-02-05
HU9602263D0 (en) 1996-10-28
EP0748317A1 (en) 1996-12-18

Similar Documents

Publication Publication Date Title
AU2070795A (en) 3-aryl-4-hydroxy-delta3-dihydrothiophenone derivatives
AU695661B2 (en) 5-membered heteroaryl-oxazolidinones
AU7159994A (en) 3-aryl-4-hydroxy-delta3-dihydrofuranone derivatives
AU3698295A (en) Amino purine-beta -d-ribofuranuronamide derivatives
AUPN012194A0 (en) Alumino-silicate derivatives
AU4317396A (en) Novel thiazolidin-4-one derivatives
AU2485595A (en) 1-Pyridyltetrazolinone derivatives
AUPN029994A0 (en) Alkypolysaccharide derivatives & compositions
AU6937196A (en) Benzothiazolone derivatives
AU694626B2 (en) Thiazole derivatives
AU9001598A (en) Thiourea derivatives
AU3039895A (en) Cephalosporin derivatives
AU4117396A (en) Morpholinoethylamide derivatives
AU689566B2 (en) DC-89 derivatives
AU1382595A (en) Factor viii derivatives
AU3619695A (en) Thioquinolone derivative
AU1454895A (en) Diphenyloxazoline derivatives
AU1870295A (en) Novel derivatives of tetramethylcyclopropane
AU3784595A (en) Antineoplastic cyclolignan derivatives
AU4260296A (en) Novel pyrimidinyloxy- and pyrimidinylamino-ethylphenyl-dioxolane derivatives
AU4300696A (en) Substituted m-biphenyloxazoline derivatives
AU3709593A (en) N-methyldeacetylcolchiceinamide derivatives
AU1496392A (en) Novel thiazole derivatives
AU1110497A (en) Thiazole derivatives
AU1385595A (en) Aryl-5-methylene-oxazole derivatives